RVLPQ RVL Pharmaceuticals

Watchlist

15min DelayClose Nov 27 16:00 ET

111.41Market Cap0.00P/E (TTM)

RVL Pharmaceuticals Key Stats

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/Q2	8.258M / 10.254M	--
--	2023/Q1	8.832M / 9.197M	--
--	2022/Q4	9.807M / 12.730M	--
--	2022/Q3	10.022M / 10.028M	--
--	2022/Q2	8.448M / 8.519M	--

DatePeriodRevenue/EstimateEarnings Call

--2023/Q28.258M / 10.254M--

--2023/Q18.832M / 9.197M--

--2022/Q49.807M / 12.730M--

--2022/Q310.022M / 10.028M--

--2022/Q28.448M / 8.519M--

Unlock Free Earnings Estimates

Open Account

No Data

No Data

Overall

No Data